Skip to main content
. 2021 Apr 6;23(5):456–461. doi: 10.4103/aja.aja_13_21

Table 2.

Sociodemographic characteristics and descriptive statistics of the whole cohort according to substances of abuse use (n=7447)

Parameters Never users Former users Current users P
Patients, n (%) 6879 (92.4) 378 (5.1) 190 (2.6)
Age (year) <0.001
 Median (IQR) 43 (34–58) 35 (30–42)* 34 (30–41)*
 Range 18–85 18–85 18–66
BMI (kg m−2) <0.01
 Median (IQR) 25 (23–27) 25 (22–26)* 25 (23–27)
 Range 15–51 18–39 18–42
CCI score <0.001
 Median (IQR) 0 (0–1) 0 (0–1) 0 (0–2)
 Mean (s.d.) 0.2 (0.3) 0.1 (0.2) 0.1 (0.2)
 Range 0–9 0–6 0–8
CCI ≥1, n (%) 1049 (15.2) 36 (9.5) 14 (7.4) <0.001
Smoking status, n (%) <0.001
 Nonsmokers/former smokers 5255 (76.4) 183 (48.5) 58 (30.6)
 Active smokers 1624 (23.6) 195 (51.5) 132 (69.4)
Smoking quantity, n (%) 0.02
 Moderate smokers 1041 (15.1) 123 (32.5) 67 (35.2)
 Heavy smokers 583 (8.5) 72 (19.0) 65 (34.2)
Alcohol consumption, n (%) <0.001
 Never 1217 (17.7) 31 (8.2) 13 (6.8)
 Active consumption 5662 (82.3) 347 (91.8) 177 (93.2)
Alcohol quantity, n (%) <0.001
 Moderate drinkers 4088 (59.4) 222 (58.7) 109 (57.3)
 Heavy drinkers 1574 (22.8) 125 (33.1) 68 (35.7)
Type of SoA, n (%)
 Cannabis/marijuana/hashish 353 (93.4) 147 (77.4) 0.001
 Cocaine 84 (22.2) 53 (27.9) 0.14
 Heroin (different forms) 7 (1.9) 10 (5.3) 0.02
 Other illicit drugs 2 (0.5) 23 (12.1) 0.01

P value according to the Kruskal–Wallis test and the Fisher’s exact test, as indicated. *P<0.01 for selected group versus never users. BMI: body mass index; CCI: Charlson Comorbidity Index; SoA: substances of abuse; –: no data; s.d.: standard deviation; IQR: interquartile range